Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-2389

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2389 3)

Pdp (68071 2389 3)
NuCare Pharmaceuticals, Inc. is the manufacturer of Atorvastatin Calcium 10mg tablets. Each film-coated tablet consists of Atorvastatin Calcium equivalent to Atorvastatin 10mg, and comes in an oval shape, white to off-white color with FF1 debossed on one side. The product contains 30 tablets packaged with lot number 00000 and National Drug Code (NDC) 68071-2389-3. The medication is only available through a prescription, and individuals should consult their doctor for medical advice about side effects. The FDA may report side effects at 1-800-FDA-1088, and the medication should be stored at a controlled temperature of 68-77°F.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 1)

FDA Label Image

Figure (Atorvastatin Calcium Figure 2)

Figure (Atorvastatin Calcium Figure 2)
The text is providing information on a clinical trial comparing the effects of a placebo to atorvastatin on a primary endpoint. The data includes the cumulative hazard percentage, along with a graph of the time to the first primary endpoint over a four-year follow-up period. The hazard ratio and p-value are also provided.*
FDA Label Image

Figure (Atorvastatin Calcium Figure 3)

Figure (Atorvastatin Calcium Figure 3)
This is a statistical report that shows the percentage of subjects experiencing an event. The report outlines the percentage values for the subjects and the dosage of Atorvastatin administered to them, with corresponding hazard ratios and p-values. The graph displays the time taken for the major cardiovascular endpoint to occur in years.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.